Home Newsfeeds Centessa Pharmaceuticals Q3 EPS $(0.57) Down From $(0.45) YoY

Centessa Pharmaceuticals Q3 EPS $(0.57) Down From $(0.45) YoY

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.

News
Tech

Tesla’s FSD Confidence Grows: Touts Equipped Vehicle Can Drive Itself With ‘Minimal Driver Intervention’ Almost Anywhere

By Anan Ashraf

September 3, 11:11 PM

EV giant Tesla Inc (NASDAQ:TSLA) is seemingly getting more confident in its full self-driving capabilities. “Your car will…

TSLA

Don’t Panic Yet! Ahead Of Key April Inflation Data, Economist Points To Charts That Hint At ‘Some Good News’ — ‘Fed Beige Book Nailed This’

By Shanthi Rexaline

May 15, 5:03 AM

The Federal Reserve's focus on bringing inflation down to its 2% target has made investors closely watch economic data releases. This week's Consumer Price Index report could provide clues about the future path of interest rates.

TIP

News

Applied Materials To Extend Global Leadership In Semiconductor Manufacturing Technology

By Benzinga Newsdesk

December 20, 5:13 PM

Applied Materials, Inc. today announced its intention to make multi-billion-dollar investments in its innovation infrastructure in the United States and to expand its global manufacturing capacity between now and 2030.

AMAT